Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy cannot be bought over the counter in the UK. It is a Prescription-Only Medicine (POM), which means a registered prescriber must assess you before any supply is legal — no pharmacy shelf, no walk-in purchase. If you've been searching for a quicker route and hitting dead ends, that frustration is completely understandable. The short answer is that the only legal path is a clinical assessment, either through the NHS or a regulated private service. Semaglutide, the active ingredient in Wegovy, sits firmly in the prescription-only category under the Human Medicines Regulations 2012, and the MHRA has been clear that GLP-1 medicines are not intended for use outside proper clinical supervision.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy's prescription-only status is not a technicality. It reflects the clinical reality that semaglutide changes how your body handles appetite, digestion and blood sugar, and it interacts with other medicines, including the contraceptive pill, where NHS guidance recommends discussing pill absorption with your prescriber before starting. A prescriber needs to review your full picture before treatment begins. The NHS medicines page for semaglutide lists the contraindications and cautions that make this assessment essential, not optional.
If you have been wondering whether Wegovy is available over the counter, the short answer is no: there is no legal version of Wegovy on a pharmacy shelf, no online basket you can fill without completing a clinical questionnaire, and no legitimate seller who will dispatch it based on a self-declaration alone. Any site offering that is either selling a product without a valid prescription chain (which is illegal) or, worse, selling something that is not Wegovy at all.
The market for unverified weight-loss injections online is large and dangerous. The MHRA has seized large quantities of fake and unlicensed weight-loss pens (some containing insulin rather than semaglutide) from sellers operating outside the regulated supply chain. Counterfeit pens have caused hospitalisations. The risk is not theoretical; enforcement operations have run throughout 2024 and 2025, including the first raid on a UK site producing counterfeit tirzepatide pens. You can read more about how to spot the red flags on our page about counterfeit semaglutide.
The warning signs are consistent: prices well below the market, no requirement for a medical questionnaire, payment processed through unfamiliar channels, and no verifiable pharmacy registration. You can check any online pharmacy against the GPhC register at pharmacyregulation.org/registers in under a minute. If the pharmacy is not listed, stop there.
The NHS route to Wegovy exists, but it runs through specialist weight management services and waiting lists can be long. For people who do not meet the current NHS criteria or cannot wait, a regulated private pharmacy is the legal alternative. The process is straightforward: complete a clinical consultation (free at nume), have your answers reviewed by a GPhC-registered Independent Prescriber, pass identity and weight verification, and (if approved) receive your treatment. A real clinician reads your questionnaire the same day; it does not go into an automated queue.
If you want to understand what Wegovy treatment involves before starting, the Wegovy treatment overview covers how the medicine works, the dose schedule, and what to expect in the first weeks. For context on what private treatment costs and what that price genuinely includes, the Wegovy prices page sets it out plainly. Worth checking before you commit anywhere.
Even through a private route, not everyone will be suitable. The licensed eligibility thresholds for Wegovy are a BMI of 30 or above, or 27 to 29.9 alongside at least one weight-related condition such as high blood pressure, high cholesterol or obstructive sleep apnoea. Lower BMI thresholds can apply for certain ethnic backgrounds under UK guidance. A prescriber also considers your medical history, conditions including a personal or family history of medullary thyroid carcinoma, pancreatitis or certain gastrointestinal disorders mean Wegovy would not be appropriate. Pregnancy, breastfeeding and trying to conceive are also situations where it is not recommended.
The weight-loss treatments overview gives a broader picture of the options regulated pharmacies can provide. It is also worth reading about whether semaglutide is available over the counter more generally, since the same rules apply across all brands and formulations. Our clinical team reviews every application personally, the assessment is thorough precisely because treatment outcomes depend on it being so.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.